Feasibility of evaluating AI-enabled digital symptom monitoring in metastatic patients with NSCLC receiving pembrolizumab therapy: A German single-arm observational pilot study

Feasibility of evaluating AI-enabled digital symptom monitoring in metastatic patients with NSCLC receiving pembrolizumab therapy: A German single-arm observational pilot study

Introduction Close symptom monitoring can benefit patients with metastatic nonsmall cell lung cancer (mNSCLC) receiving first-line therapy. Remote patient monitoring technologies, like the artificial intelligence (AI)-enabled Kaiku ® Health platform that allows oncology patients to report their heal...

Full description

Saved in:
Bibliographic Details
Main Authors: Melissa L. Santorelli, Oliver Schmalz, Mathias Hoiczyk, David Heigener, Clemens Schulte, Markus Knott, Petra Hoffknecht, Joonas Vainio, Thomas Burke, Josephine M. Norquist, Sabine Riehl, Alexander Hildner, Lisa Barthuber, Sabine Bohnet
Format: Article
Language:English
Published: SAGE Publishing 2025-07-01
Series:Digital Health
Online Access:https://doi.org/10.1177/20552076251348584
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1177/20552076251348584

Similar Items